Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$107.38 n/a | n/a%
02/27/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 108.97M 71.91M 64.54M 48.97M
Cost of Sales 5.57M 5.81M 2.79M 3.07M
Gross Operating Profit 103.40M 66.11M 61.75M 45.90M
Selling, General, and Administrative Expenses 26.62M 25.40M 23.65M 18.54M
Research & Development 21.22M 13.38M 12.12M 9.27M
Operating Income before D & A (EBITDA) 55.56M 27.33M 25.98M 18.09M
Depreciation & Amortization 10.64M 12.90M 6.35M 2.66M
Interest Income n.a. 0.00 0.00 0.00
Other Income - Net -36.96M 24.95M -3.46M -3.66M
Special Income / Charges n.a. 0.00 0.00 -480.00K
Total Income Before Interest Expenses (EBIT) 7.96M 34.23M 16.16M 11.28M
Interest Expense 0.00 11.80M 4.86M 2.08M
Pre-Tax Income 7.96M 22.43M 11.30M 9.21M
Income Taxes 10.33M -192.12M 410.00K 374.00K
Minority Interest 0.00 -2.38M -1.13M 0.00
Net Income From Continuing Operations -2.37M 227.44M 10.89M 8.83M
Net Income From Discontinued Operations 731.00K 0.00 0.00 2.59M
Net Income From Total Operations -1.64M 227.44M 10.89M 11.42M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -1.64M 229.82M 12.02M 11.42M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 227.44M 10.89M 9.31M
Preferred Dividends
Net Income Available To Common 0.00 227.44M 10.89M 8.83M
Basic EPS from Continuing Ops. -0.11 11.61 0.59 0.43
Basic EPS from Discontinued Ops. 0.04 0.00 0.00 0.13
Basic EPS from Total Operations -0.07 11.61 0.59 0.56
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) -0.01 0.00 0.00 0.00
Basic EPS, Total -0.08 11.61 0.59 0.56
Basic Normalized Net Income/Share n.a. 11.61 0.59 0.45
EPS fr Continuing Ops. -0.11 10.83 0.56 0.43
EPS fr Discontinued Ops 0.04 0.00 0.00 0.12
EPS fr Total Ops. -0.07 10.83 0.56 0.55
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -0.01 0.00 0.00 0.00
EPS, Total -0.08 10.83 0.56 0.55
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 10.83 0.56 0.45
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases

Partner Headlines for LGND

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter